Regenerative medicine company encouraged by heart failure trial

Regenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients.At 12 months, heart failure patients treated with the company’s stem cell therapy showed “significant” improvements in two key measures — a six-minute distance-walking test, as well as the Minnesota Living with Heart Failure [...]

[Read more of this report]


Cleveland Clinic physician-entrepreneur Marc Penn leaving CCF

One of Northeast Ohio’s leading physician-entrepreneurs is leaving Cleveland Clinic to join Akron’s Summa Health System.Dr. Marc Penn will become director of research for the Summa Cardiovascular Institute and also a professor at Northeast Ohio Medical University (NEOMED) in Rootstown, according to a statement from Summa. Penn will start with Summa next month. His five-person [...]

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics